In Stock: Neulasta Biosimilar (Fulphila, Pegfilgrastim-jmdb) 6mg/0.6mL (Click Here)
Prevention of Chemotherapy-Induced Neutropenia
– 6 mg SC once per chemotherapy cycle, beginning at least 24 hours after completion of chemotherapy
– Do not administer in the period between 14 days before and 24 hours after administration of cytotoxic chemotherapy.
Hematopoietic Radiation Injury Syndrome (Acute)
– 6 mg SC once weekly for 2 doses
Manufacturer: Mylan
Find a Physician:
SC Administration
– Administer subcutaneously
– Do not use 6 mg fixed dose in infants, children, or adolescents <45 kg
Pegfilgrastim is available in prefilled syringes for manual subcutaneous administration or as a kit for use with the On-body injector
– Direct administration of doses <6 mg using the prefilled syringe is not recommended by the manufacturer (it does not have graduation marks necessary for accurate measurement of doses other than 6 mg)
– Use caution to avoid dosing errors
Storage
– Store under refrigeration at 2°C to 8°C (36°F to 46°F)
– Do not freeze.
– If syringe for manual injection is inadvertently frozen, allow to thaw in refrigerator; discard if frozen more than one time
– Protect from light.
– Do not shake.
